Molecule Details
InChIKeyQJJXYPPXXYFBGM-LFZNUXCKSA-N
Compound NameTacrolimus
Canonical SMILESC=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)11
Pfam Stratification Cross-Family
Avg pChEMBL7.43
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00864
Drug NameTacrolimus
CAS Number104987-11-3
Groups approved investigational
ATC Codes D11AH01 L04AD02
DescriptionTacrolimus (also FK-506 or Fujimycin) is an immunosuppressive drug whose main use is after organ transplant to reduce the activity of the patient's immune system and so the risk of organ rejection. It is also used in a topical preparation in the treatment of severe atopic dermatitis, severe refracto...

Categories: Agents Causing Muscle Toxicity Agents causing hyperkalemia Agents for Dermatitis, Excluding Corticosteroids Antineoplastic and Immunomodulating Agents Calcineurin Inhibitor Immunosuppressant Calcineurin Inhibitors Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dermatologicals Drugs causing inadvertant photosensitivity Enzyme Inhibitors Hyperglycemia-Associated Agents Immunologic Factors Immunosuppressive Agents Lactones Misc. Skin and Mucous Membrane Agents Myelosuppressive Agents Narrow Therapeutic Index Drugs Nephrotoxic agents OATP1B1/SLCO1B1 Inhibitors P-glycoprotein inducers P-glycoprotein inhibitors P-glycoprotein substrates P-glycoprotein substrates with a Narrow Therapeutic Index Photosensitizing Agents Polyketides Potential QTc-Prolonging Agents QTc Prolonging Agents
Cross-references: BindingDB: 50079777 ChEBI: 61049 CHEMBL269732 ChemSpider: 393220 Drugs Product Database (DPD): 167 C01375 D00107 PDB: FK5 PharmGKB: PA451578 PubChem:445643 PubChem:46506004 RxCUI: 235991 Therapeutic Targets Database: DAP000162 Wikipedia: Tacrolimus ZINC: ZINC000169289411
Target Activities (11)
Target Gene Organism Category Pfam pChEMBL Type Source
P68106 FKBP1B Homo sapiens Human PF00254 9.4 Kd ChEMBL;BindingDB
P62942 FKBP1A Homo sapiens Human PF00254 8.8 IC50 ChEMBL;BindingDB
P42345 MTOR Homo sapiens Human PF02259 PF02260 PF08771 PF23593 PF11865 PF00454 8.8 IC50 ChEMBL;BindingDB
Q15393 SF3B3 Homo sapiens Human PF10433 PF23726 PF03178 7.9 IC50 ChEMBL
Q08209 PPP3CA Homo sapiens Human PF00149 7.8 IC50 ChEMBL;BindingDB
Q02790 FKBP4 Homo sapiens Human PF00254 PF00515 PF07719 7.2 Kd ChEMBL
Q13451 FKBP5 Homo sapiens Human PF00254 PF00515 PF13181 7.1 Ki ChEMBL;BindingDB
P08684 CYP3A4 Homo sapiens Human PF00067 6.2 IC50 ChEMBL;BindingDB
P20815 CYP3A5 Homo sapiens Human PF00067 6.2 IC50 ChEMBL;BindingDB
P24462 CYP3A7 Homo sapiens Human PF00067 6.2 IC50 ChEMBL
Q9HB55 CYP3A43 Homo sapiens Human PF00067 6.2 IC50 ChEMBL
DrugBank Target Actions (11)
Target Gene Target Name Action Type
P02763 P02763 Alpha-1-acid glycoprotein 1 substrate carriers
P02768 ALB Albumin substrate carriers
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P20815 CYP3A5 Cytochrome P450 3A5 substrate enzymes
P62942 FKBP1A Peptidyl-prolyl cis-trans isomerase FKBP1A inhibitor targets
Q08209 PPP3CA Protein phosphatase 3 catalytic subunit alpha inhibitor targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inducer transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
Q9Y6L6 SLCO1B1 Solute carrier organic anion transporter family member 1B1 inhibitor transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters
Q8WWZ7 Q8WWZ7 Cholesterol transporter ABCA5 substrate transporters